Cargando…
Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain
The activation of Translocator protein (18 kDa) (TSPO) has been demonstrated to mediate rapid anxiolytic efficacy in stress response and stress-related disorders. This protein is involved in the synthesis of endogenous neurosteroids that promote γ-aminobutyric acid (GABA)-mediated neurotransmission...
Autores principales: | Wang, Dong-sheng, Tian, Zhen, Guo, Yan-yan, Guo, Hong-liang, Kang, Wen-bo, Li, Shuo, Den, Ya-ting, Li, Xu-bo, Feng, Bing, Feng, Dan, Zhao, Jian-ning, Liu, Gang, Zhao, Ming-gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393609/ https://www.ncbi.nlm.nih.gov/pubmed/25889665 http://dx.doi.org/10.1186/s12990-015-0013-6 |
Ejemplares similares
-
Antidepressant-like effects of translocator protein (18 kDa) ligand ZBD-2 in mouse models of postpartum depression
por: Li, Xu-bo, et al.
Publicado: (2018) -
The New Dipeptide TSPO Ligands: Design, Synthesis and Structure–Anxiolytic Activity Relationship †
por: Gudasheva, Tatiana A., et al.
Publicado: (2020) -
Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice
por: Li, Xiao-ming, et al.
Publicado: (2017) -
The antidepressant-like activity of AC-5216, a ligand for 18KDa translocator protein (TSPO), in an animal model of diabetes mellitus
por: Qiu, Zhi-Kun, et al.
Publicado: (2016) -
Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination
por: Sokias, Renee, et al.
Publicado: (2016)